Bing Yang

Dr. Bing Yang

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2021 in Science Advances
Verified
Journal Article
Open access
XMXiaoyu Mu
Xiaoyu Mu
JWJunying Wang
Junying Wang
HHHua He
Hua He
QLQifeng Li
Qifeng Li
BYBing Yang
Bing Yang
XZXiaodong Zhang
Xiaodong Zhang
An oligomeric nanozyme with ultrafast electron transfer can achieve high catalytic activity and alleviate acute brain injury.

1 December 2020 in DNA and Cell Biology
Verified
Journal Article
Closed access
LQLiyu Qian
Liyu Qian
QFQiaoman Fei
Qiaoman Fei
HZHaoran Zhang
Haoran Zhang
MQManman Qiu
Manman Qiu
BZBo Zhang
Bo Zhang
BYBing Yang
Bing Yang
Mounting evidence shows that long noncoding RNAs play important roles in human diseases and radioresistance could be an important factor for tumor recurrence. We observed that HOX antisense intergenic RNA (HOTAIR) expression increased in invasive ductal carcinoma (IDC) tissue. The irradiation effect of HOTAIR was detected by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, cell cycle and apoptosis analysis, and xenografts in nude mice. Western blot, RNA pulldown assay, and RNA immunoprecipitation were used for mechanistic studies. HOTAIR, upregulated in IDC of breast cancer tissue, could promote breast cancer cell proliferation by regulating cell cycle and apoptosis. Overexpression of HOTAIR promoted DNA damage repair factors KU70, KU80, DNA-PKs, and ATM expression, and these could be impeded by small molecular inhibitors of enhancer of zeste homolog 2 (EZH2). Meanwhile, we found that HOTAIR could facilitate recruitment of EZH2 to the Avian Myelocytomatosis Viral Oncogene Homolog (MYC) promoter. HOTAIR is an important modulator not only to the prognostic of breast cancer, but also a good marker for radiotherapy.

9 June 2023 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
LQLiyu Qian
Liyu Qian
LLLi Li
Li Li
YLYang Li
Yang Li
SLShen Li
Shen Li
BZBo Zhang
Bo Zhang
BYBing Yang
Bing Yang

6 December 2022 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
LWLei Wang
Lei Wang
MQManman Qiu
Manman Qiu
LWLili Wu
Lili Wu
ZLZexing Li
Zexing Li
XMXinyi Meng
Xinyi Meng
BYBing Yang
Bing Yang
Background: Hepatocellular carcinoma (HCC) is a frequent primary liver cancer, and it is one of the leading cause of cancer-related deaths. Hepatitis B virus (HBV) infection is a crucial risk factor for HCC. Thus, this study aimed to explore the prognostic role of HBV-positive HCC related specific genes in HCC. Methods: The HCC related data were downloaded from three databases, including The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC), and Gene Expression Omnibus (GEO). Univariate Cox regression analysis and LASSO Cox regression analysis were conducted to build the Risk score. Multivariate Cox regression analysis and survival analysis determined the independent prognostic indicators. Results: After cross analysis of differentially expressed genes (DEGs), we have identified 106 overlapped DEGs, which were probably HBV-positive HCC related specific genes. These 106 DEGs were significantly enriched in 213 GO terms and 8 KEGG pathways. Among that, 11 optimal genes were selected to build a Risk score, and Risk score was an independent prognostic factor for HCC. High risk HCC patients had worse OS. Moreover, five kinds of immune cells were differentially infiltrated between high and low risk HCC patients. Conclusion: The prognostic signature, based on HMMR, MCM6, TPX2, KIF20A, CCL20, RGS2, NUSAP1, FABP5, FZD6, PBK, and STK39, is conducive to distinguish different prognosis of HCC patients.

Verified
Journal Article
Open access
PDF file
QWQin Wang
Qin Wang
ZSZhijuan Sun
Zhijuan Sun
LDLiqing Du
Liqing Du
CXChang Xu
Chang Xu
YWYan Wang
Yan Wang
Qiang LiuQiang Liu
Qiang Liu
Colorectal cancer is the most commonly reported gastrointestinal malignancy, with a recent, rapid increase of the annual incidence all over the world. Enhancing the radiosensitivity of cancer cells while preserving the health of normal cells is one of the most important tasks in clinical radiobiology. However, resistance to radiotherapy for colorectal cancer greatly decreases the therapeutic outcome. Melatonin (N-acetyl-5-methoxytryptamine), a natural secretory product that the pineal gland in the brain normally produces, has been reported to have anticancer properties. In the study, we investigated the combination of melatonin with radiotherapy as a treatment for colorectal cancer. We firstly explored the anti-tumor activity of melatonin combined with ionizing radiation (IR) against colorectal carcinoma in vitro. It was found that melatonin effectively inhibited human colorectal carcinoma cell line HCT 116 cellular proliferation, colony formation rate and cell migration counts following IR. Increasing the radiosensitivity of colorectal cancer cells by melatonin treatment was found to be associated with cell cycle arrest in the G2/M phase, downregulation of proteins involved in DNA double-strand break repair and activation of the caspase-dependent apoptotic pathway. Moreover, we also investigated the combined effect of IR and melatonin on colorectal tumor in vivo. Results from a tumor xenograft showed that melatonin plus IR treatment significantly suppressed tumor cell growth compared with melatonin or IR alone, resulting in a much higher tumor inhibition rate for the combined treatment. The data suggested that melatonin combined with IR could improve the radiosensitivity of colorectal cancer and thus enhance the therapeutic effect of the patients, implying melatonin could function as a potential sensitizer in tumor radiotherapy.

7 February 2023 in STAR Protocols
Verified
Journal Article
Open access
WSWenbo Sun
Wenbo Sun
JGJi Gao
Ji Gao
BYBing Yang
Bing Yang
XCXiangjun Chen
Xiangjun Chen
NKNa Kang
Na Kang
WLWanli Liu
Wanli Liu
Inflammatory bowel diseases (IBDs) contribute to the tumorigenesis of colorectal cancer (CRC). Here, we describe a step-by-step protocol for the construction of colitis-associated CRC murine model by sequential utilization of azoxymethane and dextran sulfate sodium. We also detail steps to determine the degree of murine intestinal inflammation and to generate colorectum Swiss roll for further histopathological analyses. This is a convenient and reproducible protocol for colitis-associated CRC murine model by the induction of general chemical reagents. For complete details on the use and execution of this protocol, please refer to Yang et al. (2022).1.